Anondita Medicare (NSE:ANONDITA) EBIT: ₹504 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:ANONDITA Anondita Medicare Ltd NSE:ANONDITA
21 GF Score
Price ₹1,054.60
! 4 Warning Signs
View Full Analysis

What is Anondita Medicare EBIT?

Anondita Medicare NSE:ANONDITA -1.90% 21 EBIT is ₹504 Mil as of Mar. 2026. GuruFocus rates NSE:ANONDITA with a GF Score™ of 21/100. The stock has 4 warning signs investors should review.

Anondita Medicare's earnings before interest and taxes (EBIT) for the six months ended in Mar. 2026 was ₹312 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹504 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Anondita Medicare's annualized ROC % for the quarter that ended in Mar. 2026 was 29.55%. Anondita Medicare's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 56.79%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Anondita Medicare's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 2.61%.

Anondita Medicare  (NSE:ANONDITA) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Anondita Medicare's annualized ROC % for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Sep. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=615.85 * ( 1 - 27.9% )/( (1334.251 + 1671.514)/ 2 )
=444.02785/1502.8825
=29.55 %

where

Invested Capital(Q: Sep. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1763.052 - 63.705 - ( 365.096 - max(0, 528.72 - 1444.249+365.096))
=1334.251

Invested Capital(Q: Mar. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1848.312 - 80.279 - ( 96.519 - max(0, 275.784 - 985.209+96.519))
=1671.514

Note: The Operating Income data used here is two times the semi-annual (Mar. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

Anondita Medicare's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Sep. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=624.542/( ( (279.933 + max(515.044, 0)) + (805.926 + max(598.762, 0)) )/ 2 )
=624.542/( ( 794.977 + 1404.688 )/ 2 )
=624.542/1099.8325
=56.79 %

where Working Capital is:

Working Capital(Q: Sep. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(480.967 + 145.01 + 82.549) - (63.705 + 0 + 129.777)
=515.044

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(518.567 + 207.501 + 51.166) - (80.279 + 0 + 98.193)
=598.762

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Mar. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Anondita Medicare's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2026 )
=504.276/19331.977
=2.61 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Anondita Medicare EBIT Related Terms

Anondita Medicare EBIT Historical Data

* Premium members only.

The historical data trend for Anondita Medicare's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Anondita Medicare EBIT Chart

Anondita Medicare Annual Data
Trend Mar22 Mar23 Mar24 Mar25 Mar26
EBIT
36.54 31.77 85.59 250.33 504.28

Anondita Medicare Semi-Annual Data
Mar22 Mar23 Mar24 Sep24 Mar25 Sep25 Mar26
EBIT Get a 7-Day Free Trial 0.00 94.65 155.68 192.01 312.27

NSE:ANONDITA vs PG, CL, KVUE: EBIT Comparison

For the Household & Personal Products subindustry, Anondita Medicare's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Anondita Medicare EV-to-EBIT vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Anondita Medicare's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Anondita Medicare's EV-to-EBIT falls into.


NSE:ANONDITA
21GF Score
Anondita Medicare Ltd NSE:ANONDITA
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Anondita Medicare EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹504 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of ₹504 Mil mean?
Anondita Medicare (NSE:ANONDITA) has a EBIT of ₹504 Mil as of Mar. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Anondita Medicare.
Is Anondita Medicare's EBIT too high?
Anondita Medicare's current EBIT is ₹504 Mil. Overall, Anondita Medicare has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does Anondita Medicare's EBIT compare to PG and CL?
Anondita Medicare's EBIT of ₹504 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Consumer Packaged Goods company?
A good EBIT depends on the Consumer Packaged Goods industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Anondita Medicare. Anondita Medicare's current EBIT is ₹504 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Anondita Medicare stock overvalued right now?
Anondita Medicare (NSE:ANONDITA) has a current EBIT of ₹504 Mil. The current EBIT is ₹504 Mil. Anondita Medicare's overall GF Score™ is 21/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Anondita Medicare (NSE:ANONDITA), the current EBIT is ₹504 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Anondita Medicare Business Description

Address D-001, Sector 80, Gautam Budh Nagar, Noida, UP, IND, 201301
Anondita Medicare Ltd is a manufacturer of male condoms with a variety of flavors, with its flagship product marketed and sold under the brand COBRA. It has an installed production capacity of nearly 562 million condoms per annum.
21GF Score

Get the complete analysis for NSE:ANONDITA

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,054.60
Price